EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications

Tram Thi-Ngoc Nguyen, Tomohiro Kurokawa iD, Yoshiaki Kanemoto, Takahiro Sawada, Shigeaki Kato iD

Biomolecules · 2026

DOI: 10.3390/biom16030396 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Tram Thi-Ngoc Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Iryo Sosei University, Iino, Chuo-dai, Iwaki 970-8551, Fukushima, Japan. Hauptthemen laut MEDLINE: Receptors, Calcitriol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS, Tokiwa Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D signaling via the vitamin D receptor (VDR) regulates calcium–phosphate homeostasis and extensive gene programs controlling cell proliferation, differentiation, immune tone, and metabolism. However, systemic use of the natural agonist 1α,25-dihydroxyvitamin D3 (calcitriol) for extraskeletal indications is limited by dose-limiting hypercalcemia. This review summarizes VDR biology and the structural basis of ligand action, emphasizing how ligand-induced repositioning of helix 12 and altered coregulator recruitment can be exploited to engineer selective VDR modulators. We highlight medicinal chemistry strategies spanning secosteroidal analogs with side-chain or ring modifications and emerging non-seco scaffolds and discuss clinically established agents (e.g., calcipotriol and paricalcitol) alongside experimental “super-agonists”, partial agonists, and antagonists designed to widen the therapeutic window. Finally, we discuss current evidence for VDR targeting across cancer, metabolic disease, fibrosis, and immune-inflammatory disorders, including mechanisms of resistance such as dysregulated vitamin D metabolism and epigenetic repression. Structural and epigenomic insights are positioning next-generation VDR ligands as tissue- and pathway-biased therapeutics that may enable safer, mechanism-guided translation beyond bone and mineral indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolHumansAnimalsLigandsCalcitriolVitamin DSignal Transduction

Stichwörter der Autor:innen

Vitamin D Receptor (VDR)helix-12 conformational changehypercalcemialigand-dependent transcriptionselective nuclear receptor modulatorssynthetic vitamin D analogs

Substanzen

Receptors, CalcitriolLigandsCalcitriolVitamin D

Autor:innen und Institutionen

  • Department of Pharmacy, Iryo Sosei University, Iino, Chuo-dai, Iwaki 970-8551, Fukushima, Japan.
  • Research Institute of Innovative Medicine, Tokiwa Foundation, Iwaki 971-8112, Fukushima, Japan.
  • School of Medicine, Fukushima Medical University, Fukushima 960-1295, Fukushima, Japan.

ORCID-Profile: Tomohiro Kurokawa, Shigeaki Kato

Förderung

  • Japan Society for the Promotion of Science
  • JSPS
  • Tokiwa Medical Foundation
  • Fukushima prefecture

Zitieren

APA

Nguyen, T. T., Kurokawa, T., Kanemoto, Y., Sawada, T., & Kato, S. (2026). Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications. Biomolecules. https://doi.org/10.3390/biom16030396

Vancouver

Nguyen TT, Kurokawa T, Kanemoto Y, Sawada T, Kato S. Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications. Biomolecules. 2026. doi:10.3390/biom16030396

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Tram Thi-Ngoc and Kurokawa, Tomohiro and Kanemoto, Yoshiaki and Sawada, Takahiro and Kato, Shigeaki},
  title = {Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16030396}
}
Kostenlos starten →